Huperzine A polymorphism body, preparation method thereof, pharmaceutical composition comprising polymorphism body and application thereof
2012
The invention discloses a huperzine A polymorphism body, a preparation method thereof, a pharmaceutical composition comprising the polymorphism body and an application thereof. Partial of the huperzine A polymorphism body has better solubility than that of a commercially available medicinal crystal form and is more beneficial to absorption of medicine. Partial of the huperzine A polymorphism body has much lower hygroscopicity than that of the commercially available medicinal crystal form and is more beneficial to preparation and storage of medicine preparations.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI